Candida Krusei

If you get thrush and fluconazole doesn't clear it, the yeast behind it may belong to a species that was never going to respond. Candida krusei is one of those species. A saliva result can help show whether it's present before a treatment decision depends on the answer.

In most healthy people it turns up rarely and causes no trouble. It gets more common, and matters more, in people who smoke, wear dentures, take antibiotics or steroids, have dry mouth, or are going through cancer treatment. Those are the situations where knowing the species can change the next step.

What a Positive Result Means

A positive result means your sample contained this species, or its DNA if the test uses PCR. PCR looks for DNA rather than live yeast. The current name is Pichia kudriavzevii, so you may see either name on a report.

This yeast can be found on the tongue, gums, dental plaque, and dental hardware. Saliva normally helps keep Candida yeasts in check by washing surfaces and carrying natural antifungal proteins and antibodies. When saliva flow drops or immune defenses weaken, Candida yeasts can multiply, cling to tissue, release tissue-irritating enzymes, and build a slimy protective layer that makes treatment harder.

What sets this species apart is built-in resistance to fluconazole. Lab testing of human yeast isolates shows that pattern consistently, and the fluconazole drug label itself says to treat this species as resistant. Treatment aimed at the common species, C. albicans, may leave this one behind. Other drugs can still work, with caveats. For a serious infection that reaches the blood or organs, echinocandins are the preferred choice because resistance to them is rare. Amphotericin B works less reliably against this species and may need higher doses. Most isolates respond to voriconazole, but resistance is emerging in some regions. For thrush, the choice depends on the infection site, severity, and susceptibility testing on your own sample.

What this means for you: a positive result is mainly a treatment flag. If you ever develop thrush, the dentist or clinician treating it should know that fluconazole is likely to fail.

Who Tends to Carry It

Candida yeast can be a normal resident of the mouth. Somewhere between a quarter and more than 70% of people without mouth disease carry some Candida, and this species is usually a small slice of that. In one U.S. infant cohort that tested for three Candida species, it was one of the most common species found during the first year of life and was most often detected on the tongue.

How often it shows up depends heavily on who is being tested and how the sample is collected.

Sources, by row: Makinen et al.; Reichart et al.; Kibwana et al.

What this means for you: carriage climbs where the immune system or the mouth's environment is under strain. A positive result in someone with none of the usual risk factors is less expected, which is a reason to confirm it with a second sample and a more precise identification method.

Smoking and Gum Disease

Chronic gum disease is an infection that slowly loosens the attachment between gums and teeth, and it goes with more yeast in saliva, especially in smokers. In a study of 90 adults with gum disease, smokers carried higher salivary yeast loads, and this species ranked among the more frequent yeasts other than C. albicans in both saliva and plaque below the gumline.

Pooling studies across all Candida species, finding yeast went with about 1.76 times the odds of chronic gum disease. That figure covers yeast as a group, so it can't be pinned on this species, and these studies can't show which came first.

What this means for you: if you smoke or have gum disease, a positive result is one more reason to deal with both, and it tells your dentist that fluconazole may not be enough if a yeast infection develops.

Cancer Treatment, Steroids, and Antibiotics

People getting chemotherapy or radiation often shift away from the common yeast toward non-albicans Candida species. In the Tanzanian group above, this species was the leading yeast in people being treated for cancer, especially head, neck, and digestive cancers. Broad-spectrum antibiotics and long steroid courses also make mouth infections involving several yeast species more likely, and this species can be one of them.

Severe immune suppression points the same way. Higher carriage of fluconazole-resistant or non-albicans yeast has been reported in advanced HIV infection and in people with long-standing leprosy.

What this means for you: if you're heading into cancer treatment or a long course of steroids, a baseline result can help guide antifungal choice if thrush appears.

Mouth Lesions and Oral Cancer

Small studies have isolated this species from some cancerous and precancerous mouth lesions, but the signal is inconsistent and depends on sampling. A lesion swab picks up yeast living directly on damaged tissue, while saliva averages across the whole mouth.

In saliva samples from people with established oral squamous cell carcinoma, the most common mouth cancer, it turned up in only about 1% of Candida-positive cancer samples. Pooled studies suggest Candida as a group may be more common in oral cancer, but that work centers on C. albicans. Detecting this species in saliva is best read as a sign of a disturbed mouth environment, with no shown value for predicting cancer.

Bloodstream Infections in Hospitals

When this yeast gets into the bloodstream, it mostly affects hospitalized people with badly weakened immune systems, and it's serious. Reported death rates vary widely. Older series found crude rates as high as 44% to 67%, but much of that reflects how sick those patients already were. In one hospital series, the extra risk disappeared once lymphoma, low white blood cell counts, steroid use, and liver disease were accounted for. A 2024 analysis of a large global patient network found 90-day mortality of about 21%, similar to or lower than for C. albicans. The World Health Organization lists Pichia kudriavzevii as a medium-priority fungal pathogen.

Those figures come from blood infections, which are a different test and a different setting from a saliva sample. Carrying the yeast in your mouth has not been shown to predict a bloodstream infection in otherwise healthy people. In someone with very low white blood cell counts or in intensive care, finding a fluconazole-resistant yeast in the mouth is a reasonable extra signal when clinicians decide whether to order blood cultures or other fungal tests, though a saliva test hasn't been validated for that use.

Why a Single Reading Can Fool You

The biggest source of error is the method the lab uses to name the species.

• Identification method: color-based culture plates are useful as a first pass, but several yeasts can look similar. Species-specific DNA tests and protein-pattern identification are more precise.
• Combined readouts: some molecular platforms report this species and C. glabrata as a single result. A combined call needs a follow-up test before treatment is chosen.
• Recent antifungal use: antifungals taken before sampling can suppress live yeast and cause a false negative on culture, while DNA tests may still pick up leftover genetic material.
• Sample type and sensitivity: saliva, oral rinse, swab, and lesion samples can give different species results. Very sensitive DNA tests can detect trace amounts that don't reflect a meaningful population.

Tracking Your Pattern

Carriage of this yeast moves with your circumstances. New dentures, braces, smoking, antibiotics, steroids, dry mouth, and cancer treatment can all change the mouth environment. There's no standard cutoff for a high count when saliva is tested this way, so a series of results is more useful than a single number.

Next Steps After a Positive Result

If your first result came from a color-based culture plate, confirm the species with a DNA test or MALDI-TOF. MALDI-TOF identifies yeast by its protein pattern. This is especially useful if the report lumps it together with C. glabrata. From there, what you do depends on the pattern.

• Positive with no symptoms and no risk factors: this is most likely harmless carriage. Retest in 3 to 6 months; treating symptom-free carriage has no shown benefit and can lead to antifungals you don't need.
• Positive with smoking, gum disease, or dental hardware: get a periodontal exam and consider an oral pathogen panel. Have dentures checked for fit and cleaning routine. Check HbA1c. It reflects average blood sugar over about three months, and diabetes goes with more mouth yeast.
• Positive with white patches, redness, burning, or soreness under a denture: see a dentist or oral medicine specialist, and get susceptibility testing so the lab checks which drugs work on your specific sample. Expect a prescription other than fluconazole.
• Positive during cancer treatment or with weakened immunity: tell your oncology or infectious disease team. If fever or other signs of a wider infection appear, blood-based fungal tests are the next step.